
Social media marketing in the healthcare industry builds physician authority and spreads category narrative faster than any other channel medtech has. It also cannot close a hospital procurement committee.
Treating it like a sales channel for capital equipment is where most healthcare marketing budgets get wasted.
Key Takeaways
In healthcare marketing, social media builds authority rather than closing deals. Physicians and medtech founders who post consistently outrank the ones who don't, because almost nobody else is doing it.
I covered this on an episode about the state of sales in biotech and medtech:
"Of the 750 million LinkedIn users globally, only 3 million make content. That's about one percent of all LinkedIn users making content. You don't have to be the best. You just have to be the one who shows up and does it consistently."
That one percent gap is the whole opportunity. A physician or founder does not need production value to stand out on social media in healthcare. They need to be one of the few people in the room who showed up.
I interviewed Dr. Chester Donnally III, a spine surgeon, on an episode about how spine surgeons should use social media. He described the compounding effect of owned content directly:
"If I have content on YouTube that links back to my website, and someone types in spine surgery, that helps me jump up in the top 10 without having to pay any money."
— Dr. Chester Donnally III (The State of MedTech)
No paid social budget produced that rank. Consistent content did, which is a different mechanism than most healthcare marketing plans budget for.
Before a market recognizes a new category, the language for it has to circulate somewhere. In medtech, that somewhere is social media, specifically LinkedIn.
"Narrative A/B testing in public. When strategics start echoing your language and your category, that's when you've succeeded. You've engineered market consensus."
Watching a strategic acquirer or investor start using a founder's own category language on their own LinkedIn post is one of the clearest signals available that a market is forming.
It happens on social media first because that's where the industry's attention already concentrates, well before it shows up in a press release or a conference keynote.
Tony Recupero, President of SI-BONE, used exactly this channel to build commercial pipeline rather than just narrative. On an episode covering lessons from US Surgical, Kyphon, and SI-BONE, he said:
"In 60 days, that's only two months, I was able to put 35 deals in the pipeline of a variety of different hospitals. I essentially used LinkedIn and a few other digital channels and strategies."
— Tony Recupero, President of SI-BONE (The State of MedTech)
Recupero's pipeline came from visibility and access. Social media got him in front of the right people faster than a traditional sales cycle would have. It did not, on its own, close those 35 deals.
This is the limit founders miss most often. A hospital's decision to buy capital equipment does not run through a LinkedIn feed.
It runs through a value analysis committee, and that committee decides through an internal stakeholder map social media has no access to.
I interviewed Mark Copeland on an episode about selling to the hospital value analysis committee. He described exactly how that map gets built:
"I chart it. I put down the left-hand side, here's all the important people. Across the top I ask: are they against us, do they not care, do they love it? And I try to move everybody one step to the right."
— Mark Copeland (The State of MedTech)
No amount of social media reach moves a name on that chart. VAC members are not scrolling LinkedIn during a purchasing decision. They're weighing internal politics, budget cycles, and clinical evidence a founder's content strategy never touches directly.
This is exactly why medtech commercialization strategy treats social media as one input into a longer sales motion rather than a replacement for it.
Social builds the awareness and the narrative that gets a founder into the room. The committee still has to be won in the room.
In my experience working with medtech founders, the ones who get burned by social media spent budget expecting it to behave like a direct sales channel for capital equipment. It never will.
The founders who get value from it use it for what it does. Build physician and founder authority through consistent content, and let category language spread to the investors and strategics already watching.
Then hand the buying committee off to a commercial process built for how hospitals decide.
Social media builds the authority and category awareness that gets a medtech company into a hospital's purchasing conversation. It does not close the deal.
Hospital value analysis committees decide through internal stakeholder mapping, not through social media reach, so the channel works best paired with a commercial process built for that committee.
LinkedIn carries most of medtech's professional attention, including strategic investors, acquirers, and clinicians. YouTube works well for physician-created educational content, which compounds into organic search visibility over time without ongoing paid spend.
Consistency matters more than frequency. Only about one percent of LinkedIn's users create content at all, so showing up regularly, even without polished production, outperforms most competitors by default.
If you're doing this yourself: The State of MedTech covers how founders and physicians build authority on social media without a marketing department behind them.
If you want it engineered with you: MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For teams already running social content with no commercial process behind it, the audit maps where the handoff from narrative to buying committee is breaking down.
Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.